Rouse, Inngot launch patent valuation tool on Alibaba
Alibaba has partnered with IP firms Rouse and Inngot to launch a new patent assessment and valuation service on the Chinese company’s online auction platform, Ali Auction.
The “Intangio” service estimates patent prices by analysing sales data of historical patent transactions.
Intangio is targetting administrators appointed by courts to dispose of assets of bankrupt companies, providing guidance on the reserve prices of patents that are listed on the Ali Auction platform.
In developing the tool, Rouse and Inngot claim to have built China’s largest database of patent auction data to ensure greater accuracy when estimating prices.
Chris Bailey, a principal at Rouse Consultancy who led the Intangio project for Rouse, said: “Our data-driven approach is uniquely suited to the problem of automated and accurate IP valuation, which Ali Auctions were looking to solve.
“Intangio will give banks and insurers essential data on recoverable value, helping China—which is already a pioneer in the IP finance value chain—to further enhance its IP lending system. Outside of financial markets, Intangio provides companies with an accurate way to assess the value and quality of their patents.”
The tool provides an assessment of patent quality using proprietary metrics and provides an “attractiveness score” based on the volume of transactions, licensing and litigation activity of comparable patents.
Intangio is currently only available to users of the Ali Auctions platform but Rouse and Inngot claim they have plans to expand its use within other Alibaba Group applications.
Martin Brassell, co-founder and CEO of Inngot, said: “Intangio is part of our drive to transform IP valuation. Currently, it is often regarded as an art; Inngot is turning it into a science through the use of data analytics. This is the only way IP value can be exploited at scale, and third parties can have confidence in it.”
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories sent like this straight to your inbox
Today’s top stories
